All these results indicate that inhibition of transaminases in HCT116 colon cancer cells elicits an apoptotic response involving both FLIPL downregulation and GCN2-mediated TRAIL-R2 upregulation, mainly due to impairment of NEAA biosynthesis. This evidence concerns the gene EIF2AK4 and malignant colon neoplasm.